Phase 2 Trial of Liposomal Doxorubicin (40 mg/m2) in Platinum/Paclitaxel-Refractory Ovarian and Fallopian Tube Cancers and Primary Carcinoma of the Peritoneum - Concepedia

Concepedia

Publication | Closed Access

Phase 2 Trial of Liposomal Doxorubicin (40 mg/m2) in Platinum/Paclitaxel-Refractory Ovarian and Fallopian Tube Cancers and Primary Carcinoma of the Peritoneum

159

Citations

10

References

2000

Year

Maurie Markman, Alexander Kennedy, Kenneth Webster, Gertrude Peterson, Barbara Kulp, Jerome L. Belinson

Gynecologic Oncology

Fallopian Tube CancersMedicineMetronomic TherapyPathologyGynecologyLiposomal DoxorubicinCancer TreatmentPhase 2OncologyRadiation OncologyOvarian Cancer

References

	Year	Citations

Page 1